VENUS REMEDIES
Back to Cashflow Statement
|
VENUS REMEDIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹9.18 Cr | ₹29 Cr | ₹-15 Cr | ₹15 Cr | ₹26 Cr |
What is the latest Net Cash Inflow / Outflow ratio of VENUS REMEDIES ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2025 | ₹9.18 Cr |
| Mar2024 | ₹29 Cr |
| Mar2023 | ₹-15 Cr |
| Mar2022 | ₹15 Cr |
| Mar2021 | ₹26 Cr |
How is Net Cash Inflow / Outflow of VENUS REMEDIES Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.18 Cr | -68.35 | |
| Mar2024 | ₹29 Cr | Positive | |
| Mar2023 | ₹-15 Cr | Negative | |
| Mar2022 | ₹15 Cr | -42.89 | |
| Mar2021 | ₹26 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,338.1 Cr | -4.2% | 16.5% | 212.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹403,052.0 Cr | 0.3% | -3.7% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,336.0 Cr | 2.4% | 6.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,311.0 Cr | -0.8% | -1.5% | 25.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,264.0 Cr | 7.9% | 4.6% | 4.6% | Stock Analytics | |
| CIPLA | ₹105,484.0 Cr | 5.5% | 5.4% | -18.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -4.2% |
16.5% |
212.1% |
| SENSEX | -0.4% |
1.3% |
0.8% |
You may also like the below Video Courses